Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt

By Emily Lever · October 10, 2024, 5:45 PM EDT

Vaccine developer Gritstone bio Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday with at least $100 million of debt, saying it was in discussions with a potential bidder...

To view the full article, register now.

Bankruptcy Scorecard

Summary

A vaccine developer focused on preventative treatments for cancer and HIV filed for bankruptcy with plans to find a buyer in Chapter 11 that will continue its research.

Case Number

24-bk-12305

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$100 million to $500 million

View Full Scorecard

Documents